Close
News archive
The latest news from Karolinska Institutet.Svenskt nyhetsarkiv View compact
Dementia, Master programme
Cell and Molecular Biology, Neurodegenerative diseases
In the spring of 2016, KI researcher Tore Curstedt was nominated for a Lifetime Achievement Award by the European Patent Office for having devoted his life to Curosurf, a drug that has helped to activate the lungs of millions of preterm babies.
Innovation, Neonatology, Pediatrics, Pharmacology
Charlotte Rolny and colleagues at the Department of Oncology-Pathology have discovered a new mechanism that could be the key to a new strategy to restrict breast cancer growth.
Breast cancer, Cancer and Oncology
Obesity and overweight, Obstetrics, Pediatrics
Diabetes (en), Epigenetics, Metabolism (en), Nutrition (en)
Doctoral student, Parkinson's disease, Physiotherapy
Alumni, Collaboration, Innovation, International, Student (en)
Collaboration, Global Health, Innovation, International
Over 2,000 rapes committed against children were reported in 2015. Now, Christoffer Rahm, a specialist doctor in psychiatry and a researcher at the Department of Medicine, Huddinge, is going to investigate whether medication can prevent a person with a sexual attraction to children from offending.
Addiction research, Mental Ill-Health, Prevention (en)
Collaboration, International
Cancer and Oncology, Cell Biology, Microbiology, Tumour Biology
Care Sciences, Doctoral student
Alzheimer's disease, Dementia, Distance education
The growth factor IGF-2 can prevent the death of human nerve cells in the incurable disease ALS, according to a study by researchers at Sweden´s Karolinska Institutet and the University of Milan in Italy. The study, which is published in the journal Scientific Reports, demonstrates that degeneration-resistant oculomotor neurons can be used as a tool to identify factors able to prevent the degeneration of vulnerable neurons caused by this deadly disease.
Neurodegenerative diseases, Neurosciences